World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 22 February 2018
Main ID:  IRCT2013033112825N2
Date of registration: 2014-08-12
Prospective Registration: No
Primary sponsor: Kermanshah University Medical Sciences
Public title: The effects of folic acid in treatment of patients with depression.
Scientific title: The study of the effects of adding folic acid to the therapeutic diet (citalopram) in patients with depression.
Date of first enrolment: 2013-06-18
Target sample size: 60
Recruitment status: Complete
URL:  http://en.irct.ir/trial/12832
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.  
Phase:  2-3
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Faezeh Tatari   
Address:  Farabi Hospital, Dolat Abad street Kermanshah Iran (Islamic Republic of)
Telephone: +98 83 3727 9983
Email: ftatari@kums.ac.ir
Affiliation:  Kermanshah University of Medical Sciences
Name: Maryam Pasha Abadi   
Address:  Taleghani Hospital, Shahid Beheshti street 6717783141 Kermanshah Iran (Islamic Republic of)
Telephone: +98 83 3432 2356
Email: maryamflower98@yahoo.com
Affiliation:  Kermanshah University of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria: patients' age>18years; having diagnosis of depression (DSM.IV.TR).
Exclusion criteria: IQ less 70; schizophrenia; major medical or neurological disorders; pregnancy; any contraindications for using folates; wight lower than 30 kg; gastric or renal disorders; use of supplements such as B vitamins; chronic infections; anemia.

Exclusion criteria:

Age minimum: 18 years
Age maximum: 100 years
Gender: Both
Health Condition(s) or Problem(s) studied
Depressive episode
Depression.
Depressive episode
Intervention(s)
Adding plasbo to the therapeutic diet (citalopram) in patients with depression, for 4 month in controls.
Intervention 1: Adding folic acid (5mg/d) to the therapeutic diet (citalopram) in patients with depression, for 4 month in interventions. Intervention 2: Adding plasbo to the therapeutic diet (citalopram) in patients with depression, for 4 month in controls.
Adding folic acid (5mg/d) to the therapeutic diet (citalopram) in patients with depression, for 4 month in interventions.
Treatment - Drugs
Primary Outcome(s)
Response to trapy. Timepoint: At the beginning of study, 2 weeks later, 1 month then, After 2 months, after 3 months. Method of measurement: Beck Standard Inventory.
Secondary Outcome(s)
Response to trapy. Timepoint: At the beginning of study, 2 weeks later, 1 month then, After 2 months, after 3 months. Method of measurement: Beck Standard Inventory.
Secondary ID(s)
Source(s) of Monetary Support
Kermanshah University Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Kermanshah University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history